Haloperidol

Tracing its roots to the Ningbo Pharmaceutical Factory founded in 1956, Ningbo Dahongying Pharmaceutical Co., Ltd. is a manufacturer, exporter, importer and trading company based in Beilun, Ningbo, offering active pharmaceutical ingredients, finished dosage forms, outsourcing, custom development and consultation services across cardiovascular, cerebrovascular, endocrine, nervous system, antipyretic-analgesic and immune-regulation drug categories, alongside CMO and CDMO contract manufacturing. The company operates a dedicated R&D center focused on characteristic raw materials, special oral solid preparations and injectable generics, with development programs spanning psychiatric illness, cardiovascular and cerebrovascular disease, and anti-inflammatory treatment, maintained through long-term collaboration with Shenyang Pharmaceutical University and Zhejiang Pharmaceutical Higher Professional College; it won a third-prize Zhejiang Science and Technology Progress award and was recognized in 2018 and 2019 as an advantageous growth enterprise and key backbone enterprise by the Ningbo National High-tech Zone. Its nationwide marketing network and specialized sales team give it particular strength in psychiatric and cardiovascular/cerebrovascular drug categories, and it ships FOB, CFR, CIF and EXW under L/C and T/T terms, with sales weighted heavily toward the domestic Chinese market.